checkAd

    EANS-Tip Announcement  268  0 Kommentare Marinomed Biotech AG / Half-year financial report according to art. 125 para. 1 Stock Exchange Act

    --------------------------------------------------------------------------------
    Tip announcement for financial statements transmitted by euro adhoc with the
    aim of a Europe-wide distribution. The issuer is responsible for the content
    of this announcement.
    --------------------------------------------------------------------------------

    The company Marinomed Biotech AG is declaring the following financial reports
    below:

    Report Type: Half-year financial report according to art. 125 para. 1 Stock
    Exchange Act
    English:
    Publication Date: 30.08.2019
    Publication Location: https://www.marinomed.com/en/investors/publications


    Further inquiry note:
    Dr. Eva Prieschl-Grassauer
    Chief Scientific Officer, Marinomed
    Veterinärplatz 1, 1210 Vienna, Austria
    T +43 (0)1 250 77 4460
    E-Mail: eva.prieschl@marinomed.com
    http://www.marinomed.com

    Roland Mayrl
    Managing Partner, Metrum Communications
    Bauernmarkt 10/19, 1010 Vienna, Austria
    T +43 (0) 1 504 69 87 331
    E-Mail: r.mayrl@metrum.at
    http://www.metrum.at


    end of announcement euro adhoc
    --------------------------------------------------------------------------------

    issuer: Marinomed Biotech AG
    Veterinärplatz 1
    A-1210 Wien
    phone: 0043250774460
    FAX: 0043250774493
    mail: office@marinomed.com
    WWW: www.marinomed.com
    ISIN: ATMARINOMED6, AT0000A1WD52
    indexes:
    stockmarkets: Wien
    language: English





    Diskutieren Sie über die enthaltenen Werte



    news aktuell
    0 Follower
    Autor folgen

    Verfasst von news aktuell
    EANS-Tip Announcement Marinomed Biotech AG / Half-year financial report according to art. 125 para. 1 Stock Exchange Act - Tip announcement for financial statements transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. - The company Marinomed Biotech AG is declaring the following …

    Schreibe Deinen Kommentar

    Disclaimer